Literature DB >> 33271296

Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis.

Elizabeth Kudlaty1, Gayatri B Patel1, Michelle L Prickett2, Chen Yeh3, Anju T Peters4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33271296      PMCID： PMC8028023          DOI： 10.1016/j.anai.2020.11.014

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  9 in total

1.  Bronchiectasis in severe asthma: Clinical features and outcomes.

Authors:  Isabel Coman; Beatriz Pola-Bibián; Pilar Barranco; Gemma Vila-Nadal; Javier Dominguez-Ortega; David Romero; Carlos Villasante; Santiago Quirce
Journal:  Ann Allergy Asthma Immunol       Date:  2018-02-27       Impact factor: 6.347

2.  Bronchiectasis: new therapies and new perspectives.

Authors:  James D Chalmers; Sanjay H Chotirmall
Journal:  Lancet Respir Med       Date:  2018-02-23       Impact factor: 30.700

3.  Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series.

Authors:  Jessica Rademacher; Stefanie Konwert; Jan Fuge; Sabine Dettmer; Tobias Welte; Felix C Ringshausen
Journal:  Eur Respir J       Date:  2020-01-23       Impact factor: 16.671

4.  The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.

Authors:  Stamatoula Tsikrika; Katerina Dimakou; Andriana I Papaioannou; Georgios Hillas; Loukas Thanos; Kostantinos Kostikas; Stelios Loukides; Spyros Papiris; Nickolaos Koulouris; Petros Bakakos
Journal:  Cytokine       Date:  2017-08-31       Impact factor: 3.861

5.  Prevalence and characterization of chronic rhinosinusitis in patients with non-cystic fibrosis bronchiectasis at a tertiary care center in the United States.

Authors:  Shaan N Somani; Jason H Kwah; Chen Yeh; David B Conley; Leslie C Grammer; Robert C Kern; Michelle Prickett; Robert P Schleimer; Stephanie S Smith; Whitney W Stevens; Bruce K Tan; Kevin C Welch; Anju T Peters
Journal:  Int Forum Allergy Rhinol       Date:  2019-10-07       Impact factor: 3.858

6.  Asthma and bronchiectasis exacerbation.

Authors:  Bei Mao; Jia-Wei Yang; Hai-Wen Lu; Jin-Fu Xu
Journal:  Eur Respir J       Date:  2016-04-13       Impact factor: 16.671

7.  Upper airway involvement in bronchiectasis is marked by early onset and allergic features.

Authors:  Michal Shteinberg; Najwan Nassrallah; Jenny Jrbashyan; Nechama Uri; Nili Stein; Yochai Adir
Journal:  ERJ Open Res       Date:  2018-01-19

8.  Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab.

Authors:  Giovanna E Carpagnano; Giulia Scioscia; Donato Lacedonia; Giacomo Curradi; Maria Pia Foschino Barbaro
Journal:  J Asthma Allergy       Date:  2019-03-05

9.  Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels.

Authors:  Manel Luján; Xavier Gallardo; María José Amengual; Montserrat Bosque; Rosa M Mirapeix; Christian Domingo
Journal:  Biomed Res Int       Date:  2013-11-13       Impact factor: 3.411
  9 in total
  3 in total

1.  Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study.

Authors:  Claudia Crimi; Raffaele Campisi; Santi Nolasco; Sebastian Ferri; Giulia Cacopardo; Pietro Impellizzeri; Maria Provvidenza Pistorio; Evelina Fagone; Corrado Pelaia; Enrico Heffler; Nunzio Crimi
Journal:  J Asthma Allergy       Date:  2021-11-30

Review 2.  Guidance for Administering Biologics for Severe Asthma and Allergic Conditions.

Authors:  Delbert R Dorscheid; Jason K Lee; Warren Ramesh; Mark Greenwald; Jaime Del Carpio
Journal:  Can Respir J       Date:  2022-09-10       Impact factor: 2.130

3.  Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study.

Authors:  Vitaliano Nicola Quaranta; Silvano Dragonieri; Nunzio Crimi; Claudia Crimi; Pierachille Santus; Francesco Menzella; Corrado Pelaia; Giulia Scioscia; Cristiano Caruso; Elena Bargagli; Konstantinos Kostikas; Christos Kyriakopoulos; Nicola Scichilone; Giovanna Elisiana Carpagnano
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.